This may explain the pathogenic mechanism of miR-429 in TS, as follows: Low expression of serum miR-429 in patients with TS may not inhibit the activation of the NF-κB pathway after infection, which in turn leads to abnormal activation of microglia and then causes a neuroinflammatory response in TS. Here, NFKB1 is linked to infection.